Edition:
United States

Prana Biotechnology Ltd (PRAN.OQ)

PRAN.OQ on NASDAQ Stock Exchange Capital Market

4.55USD
29 Sep 2016
Change (% chg)

-- (--)
Prev Close
$4.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,666
52-wk High
$6.66
52-wk Low
$2.70

PRAN.OQ

Chart for PRAN.OQ

About

Prana Biotechnology Limited (Prana) is an Australia-based development stage medical biotechnology Company. The Company is engaged in commercializing research into Alzheimer's disease, Huntington disease and other major age-related degenerative disorders. The Company's lead drug candidate, PBT2 is being developed for the... (more)
No analyst recommendations are available for PRAN.OQ.

Overall

Beta: 0.05
Market Cap(Mil.): $42.79
Shares Outstanding(Mil.): 8.90
Dividend: --
Yield (%): --

Financials

  PRAN.OQ Industry Sector
P/E (TTM): -- 43.83 36.83
EPS (TTM): -2.71 -- --
ROI: -20.58 -0.29 13.93
ROE: -20.58 -2.99 14.84

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.